A cellular system for quantitation of vitamin K cycle activity: structure-activity effects on vitamin K antagonism by warfarin metabolites

Determination of total and unbound warfarin and warfarin alcohols in human plasma by high performance liquid chromatography with fluorescence detection

(2013) Tommaso Lomonaco et al.   JOURNAL OF CHROMATOGRAPHY A

Development of a chiral micellar electrokinetic chromatography–tandem mass spectrometry assay for simultaneous analysis of warfarin and hydroxywarfarin metabolites: Application to the analysis of patients serum samples

(2012) Xiaochun Wang et al.   JOURNAL OF CHROMATOGRAPHY A

VKORC1mutations detected in patients resistant to vitamin K antagonists are not all associated with a resistant VKOR activity

(2012) A. HODROGE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Functional study of the vitamin K cycle in mammalian cells

(2011) J.-K. Tie et al.   BLOOD

Novel multi-mode ultra performance liquid chromatography–tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma

(2011) Drew R. Jones et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Circulating Uncarboxylated Matrix Gla Protein Is Associated with Vitamin K Nutritional Status, but Not Coronary Artery Calcium, in Older Adults

(2011) M. Kyla Shea et al.   JOURNAL OF NUTRITION

Hydroxywarfarin Metabolites Potently Inhibit CYP2C9 Metabolism ofS-Warfarin

(2010) Drew R. Jones et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Vitamin K epoxide reductase prefers ER membrane-anchored thioredoxin-like redox partners

(2010) S. Schulman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose

(2009) Fumihiko Takeuchi et al.   PLoS Genetics